Table 1 Baseline characteristics and blood pressure parameters of patients with favorable or unfavorable outcomes after 3 months for endovascular treatment of acute large artery occlusive ischemic stroke.
Variables | Total patients (n = 587) | Favorable prognosis (n = 261) | Unfavorable prognosis (n = 326) | P |
|---|---|---|---|---|
Age, Mean ± SD | 69.02 ± 13.30 | 64.69 ± 13.45 | 72.48 ± 12.13 | < 0.001 |
BMI, Mean ± SD | 23.40 ± 3.42 | 23.66 ± 3.34 | 23.19 ± 3.46 | 0.099 |
Male, n (%) | 333 (56.73) | 160 (61.30) | 173 (53.07) | 0.045 |
Age higher than 80 years, n (%) | 132 (22.49) | 27 (10.34) | 105 (32.21) | < 0.001 |
Procedural variables | 0.924 | |||
OTA, Mean ± SD | 311.28 ± 219.38 | 305.06 ± 200.81 | 316.33 ± 233.58 | 0.546 |
OTI, Mean ± SD | 272.48 ± 229.76 | 263.38 ± 217.23 | 279.82 ± 239.47 | 0.397 |
ITP, Mean ± SD | 118.76 ± 96.91 | 110.08 ± 59.63 | 125.73 ± 118.31 | 0.062 |
PTR, Mean ± SD | 82.32 ± 66.30 | 73.74 ± 42.81 | 89.21 ± 79.75 | 0.007 |
OTR, Mean ± SD | 452.13 ± 229.74 | 434.95 ± 216.40 | 465.93 ± 239.39 | 0.119 |
OTP, Mean ± SD | 370.20 ± 218.37 | 361.75 ± 210.97 | 376.98 ± 224.25 | 0.421 |
Operation history, n (%) | 196 (33.39) | 83 (31.80) | 113 (34.66) | 0.465 |
Tirofiban treatment, n (%) | 103 (17.55) | 52 (19.92) | 51 (15.64) | 0.176 |
Stent pass attempts > 3, n (%) | 92 (15.67) | 32 (12.26) | 60 (18.40) | 0.042 |
Medical history | ||||
CIA, n (%) | 130 (22.15) | 52 (19.92) | 78 (23.93) | 0.246 |
Hyperlipemia, n (%) | 22 (3.75) | 10 (3.83) | 12 (3.68) | 0.924 |
Hypertension, n (%) | 378 (64.40) | 145 (55.56) | 233 (71.47) | < 0.001 |
CHD, n (%) | 69 (11.75) | 22 (8.43) | 47 (14.42) | 0.025 |
Diabetes, n (%) | 110 (18.74) | 29 (11.11) | 81 (24.85) | < 0.001 |
Atrial fibrillation, n (%) | 219 (37.31) | 82 (31.42) | 137 (42.02) | 0.008 |
Pre-antiplatelet, n (%) | 70 (11.93) | 35 (13.41) | 35 (10.74) | 0.321 |
Pre-anticoagulation, n (%) | 81 (13.80) | 34 (13.03) | 47 (14.42) | 0.627 |
Treatment variable | ||||
Rescue therapy#, n (%) | 105 (17.89) | 46 (17.62) | 59 (18.10) | 0.882 |
Distal escape, n (%) | 42 (7.16) | 20 (7.66) | 22 (6.75) | 0.669 |
IVT, n (%) | 344 (58.60) | 159 (60.92) | 185 (56.75) | 0.308 |
Successful recanalization (mTICI = 2B/3), n (%) | 544 (92.67) | 250 (95.79) | 294 (90.18) | 0.01 |
General anesthesia, n (%) | 303 (51.62) | 120 (45.98) | 183 (56.13) | 0.014 |
Stroke characteristics | ||||
mRS at admission, M (Q1, Q3) | 4.00 (3.00, 5.00) | 3.00 (2.00, 4.00) | 5.00 (5.00, 5.00) | < 0.001 |
NHISS > 14, n (%) | 384 (65.42) | 140 (53.64) | 244 (74.85) | < 0.001 |
Multistage thrombus, n (%) | 98 (16.70) | 39 (14.94) | 59 (18.10) | 0.308 |
TOAST classification, n (%) | 0.524 | |||
LAA | 173 (45.77) | 94 (47.72) | 79 (43.65) | |
CE | 179 (47.35) | 88 (44.67) | 91 (50.28) | |
Others or undetermined etiology | 26 (6.88) | 15 (7.61) | 11 (6.08) | |
Site of occlusion, n (%) | < 0.001 | |||
ICA | 104 (17.72) | 43 (16.48) | 61 (18.71) | |
MCA | 313 (53.32) | 162 (62.07) | 151 (46.32) | |
ICA-MCA | 58 (9.88) | 22 (8.43) | 36 (11.04) | |
BA/VA | 76 (12.95) | 17 (6.51) | 59 (18.10) | |
ACOA/PCoA | 36 (6.13) | 17 (6.51) | 19 (5.83) | |
Hospitalization complications | ||||
HT, n (%) | 191 (32.54) | 48 (18.39) | 143 (43.87) | < 0.001 |
sICH, n (%) | 120 (20.44) | 3 (1.15) | 117 (35.89) | < 0.001 |
Pulmonary infection, n (%) | 276 (47.02) | 99 (37.93) | 177 (54.29) | < 0.001 |
Liver dysfunction, n (%) | 73 (12.44) | 30 (11.49) | 43 (13.19) | 0.536 |
Respiratory failure, n (%) | 53 (9.03) | 7 (2.68) | 46 (14.11) | < 0.001 |
Blood pressure variables | ||||
Baseline SBP, M (Q1, Q3) | 145.00 (128.00, 162.00) | 142.00 (124.00, 159.00) | 148.00 (130.00, 165.00) | 0.009 |
Baseline DBP, M (Q1, Q3) | 81.00 (72.00, 91.00) | 80.00 (72.00, 90.00) | 82.00 (71.00, 92.00) | 0.672 |
Baseline PP, M (Q1, Q3) | 63.00 (49.00, 78.00) | 60.00 (46.00, 75.00) | 64.50 (52.00, 79.75) | 0.003 |
Mean SBP, M (Q1, Q3) | 126.92 (118.58, 135.02) | 124.17 (115.83, 133.50) | 128.77 (121.36, 136.30) | < 0.001 |
Mean DBP, M (Q1, Q3) | 68.04 (62.62, 74.15) | 68.75 (63.33, 75.62) | 67.82 (62.04, 72.65) | 0.013 |
Mean PP, M (Q1, Q3) | 57.45 (49.60, 66.50) | 53.08 (46.88, 61.29) | 61.12 (53.22, 69.43) | < 0.001 |
Maximum SBP, M (Q1, Q3) | 155.00 (144.00, 166.00) | 151.00 (139.00, 161.00) | 158.00 (150.00, 169.00) | < 0.001 |
Minimun SBP, M (Q1, Q3) | 103.00 (96.00, 111.00) | 102.00 (95.00, 110.00) | 104.00 (96.00, 113.00) | 0.202 |
Maximum DBP, M (Q1, Q3) | 88.00 (81.00, 98.00) | 88.00 (81.00, 98.00) | 88.00 (80.00, 98.00) | 0.804 |
Minimun DBP, M (Q1, Q3) | 53.00 (47.00, 58.00) | 53.00 (49.00, 60.00) | 52.00 (46.00, 57.00) | 0.002 |
SBP-DMM, M (Q1, Q3) | 50.00 (40.00, 62.00) | 46.00 (37.00, 58.00) | 53.00 (43.00, 65.00) | < 0.001 |
DBP-DMM, M (Q1, Q3) | 34.00 (29.00, 42.50) | 33.00 (28.00, 41.00) | 35.00 (29.00, 43.75) | 0.024 |